Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease

Journal of Neurochemistry

Volumn 75, Issue 5, 2000, Pages 2190-2199

  Pérez Navarro, Esther ^b   Canudas, Anna ^b   Akerud, Peter ^b   Alberch, J ^a   Arenas, Ernest ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Grafting; Quinolinate; Rat striatum; Survival

Indexed keywords

DNA FRAGMENT; GLUTAMATE DECARBOXYLASE; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; PREPROENKEPHALIN; PREPROTACHYKININ; PRODYNORPHIN; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; HUNTINGTON CHOREA; MALE; NERVE CELL NECROSIS; NERVE PROJECTION; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; CELL LINE; CELL TRANSPLANTATION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENKEPHALINS; FIBROBLASTS; GLUTAMATE DECARBOXYLASE; HUNTINGTON DISEASE; ISOENZYMES; MALE; NERVE GROWTH FACTORS; NEURONS; NEUROTROPHIN 3; PHOSPHORYLATION; PROTEIN PRECURSORS; QUINOLINIC ACID; RATS; RATS, INBRED F344; RECEPTOR, TRKB; TACHYKININS;

ANIMALIA; RODENTIA;

EID: 0033789409     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0752190.x     Document Type: Article

References (55)

1. TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death
2. Protective effects of neurotrophin-4/5 and transforming growth factor-α on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid
3. Anterograde transport of brain-derived neurotrophic factor and its role in the brain
4. Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease
5. Neurotrophin-4 selectively promotes survival of striatal neurons in organotypic culture
6. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo
7. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo
8. The Trk family of neurotrophin receptors
9. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
10. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer
11. The neurotrophin receptors TrkA, TrkB and TrkC are differentially regulated after excitotoxic lesion in rat striatum
12. Transcription of the Huntington disease gene during the quinolinic acid cascade
13. Neurotrophins live or let die: Does p75NTR decide?
14. Differential regulation of p21(ras) activation in neurons by nerve growth factor and brain-derived neurotrophic factor
15. A consideration of neuronal counting methods
16. The role of neuronal growth factors in neurodegenerative disorders of the human brain
17. Compartmental expression of trkB receptor protein in the developing striatum
18. Excitotoxic injury of the neostriatum: A model for Huntington's disease
19. Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development
20. Both apoptosis and necrosis occur following intrastriatal administration of excitotoxins
21. BDNF up-regulates trkB protein and prevents the death of CA1 neurons following transient forebrain ischemia
22. BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons
23. Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions
24. Cleavage of huntingtin by apopain, a preapoptotic cystein protease, is modulated by the polyglutamate tract
25. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia
26. Neurotrophic factor therapy for nervous system degenerative disorders
27. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes BAX and GADD-45 in brain areas showing DNA fragmentation
28. Intraparenchymal NGF injections in adult and aged rats induce long-lasting Trk tyrosine phosphorylation
29. Huntington's disease: Translating CAG repeat into a pathogenic mechanism
30. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neuropathological phenotype in transgenic mice
31. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells
32. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system
33. Neuronal colocalization of mRNAs for neurotrophins and their receptors in the developing central nervous system suggests a potential for autocrine interactions
34. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases
35. Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons
36. Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32 containing neurons in vitro
37. Neurotrophins promote the survival and development of neurons in the cerebellum of hypothyroid rats in vivo
38. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
39. Glial cell-line derived neurotrophic factor (GDNF) protects striatal calbindin immunoreactive neurons from excitotoxic damage
40. BDNF, NT-3 and NT-4/5 differentially regulate the phenotype and prevent degenerative changes of striatal projection neurons after excitotoxicity in vivo
41. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo
42. Recent advances in the pathogenesis of Huntington's disease
43. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
44. Differential loss of striatal projection neurons in Huntington disease
45. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients
46. Intracellular signaling pathways activated by neurotrophic factors
47. Differential utilization of Trk autophosphorylation sites
48. Expression of neurotrophins by midbrain dopaminergic neurons
49. Neuroprotective strategies involving the neurotrophins and their signaling pathways
50. Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: A possible neuroprotective mechanism of peptide growth factors
51. Effects of striatal excitotoxicity on huntingtin-like immunoreactivity
52. Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues
53. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions
54. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro
55. Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture